Tarec Elajami is a Cardiology physician. OpenAlex indexes 60 publications with 966 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2845 Aventura Blvd
Aventura, FL 331803118
Telephone
305-692-1010Provider last certified this registry record 1 Jun 2023.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20254 payments
- Boston Scientific CorporationProgram year20254 payments
- AstraZeneca Pharmaceuticals LPProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.4%Statin20.1%Atorvastatin Calcium74%Rosuvastatin Calcium20%Pravastatin Sodium6%Part D<11 patientsBeta blocker19.1%Metoprolol Succinate80%Carvedilol20%Part D≥60 patients+ 9 more classes in this area
Blood & clotting
14.1%Factor Xa inhibitor10.5%Eliquis86%Xarelto14%Part D<11 patientsP2Y12 inhibitor3.6%Clopidogrel100%Part D≥18 patientsGenitourinary & hormones
2.3%Phosphodiesterase 5 Inhibitor2.3%Sildenafil Citrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-12589-ACC C-REACTIVE PROTEIN-TRIGLYCERIDE GLUCOSE INDEX AS A PREDICTOR OF CARDIOVASCULAR MORTALITY IN HEART FAILURE
Journal of the American College of Cardiology
2026 - 26-A-12926-ACC THE C-REACTIVE PROTEIN-TRIGLYCERIDE-GLUCOSE INDEX IS AN INDEPENDENT PREDICTOR OF PERIPHERAL ARTERY DISEASE
Journal of the American College of Cardiology
2026 - 26-A-13484-ACC RACE-BASED DIFFERENCES OF C-REACTIVE PROTEIN-TRIGLYCERIDE-GLUCOSE INDEX AS A PREDICTOR OF CARDIOVASCULAR MORTALITY IN METABOLIC SYNDROME PATIENTS
Journal of the American College of Cardiology
2026 - Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression
Journal of Thoracic Disease
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”